Tag: Cancer: Breast

Skipping adjuvant regional nodal irradiation does not increase risk for recurrence or death after neoadjuvant chemo before breast-conserving surgery

Very low risk for recurrence seen for postmenopausal women aged 50 to 69 years who did not receive radiotherapy after breast-conserving surgery

Body mass index was associated with largest improvement in estimated risk for individual women

Daily or every-other-day external beam PBI regimen preferred over twice-daily regimen due to late toxicity concerns

Three-drug combination beneficial for HR-positive HER2-mutant metastatic breast cancer with prior CDK4/6i therapy

Black patients have increased mortality in refractory, sensitive disease; Asians have lower risk in refractory, sensitive, very sensitive disease

Overall survival benefit demonstrated among patients with metastatic breast cancer who had received trastuzumab and taxanes

Higher hazard ratios seen for women aged 60 to 75 years at examination, with lower mammographic breast density

Fewer than half of survey respondents could identify lesser-known symptoms

Higher levels of breast satisfaction and psychosocial and sexual well-being reported compared with alloplastic breast reconstruction